🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
In order to assess the safety of breastfed infants after their mother's pos...
Status
Completed
Location
Cochin Port Royal Hospital - Centre d'Investigation Clinique Cochin-Pasteur
Start Date
2015-02-04
Trial ID
NCT02325310
Treatments Being Tested
This research study is evaluating a combination of three drugs called lenal...
Status
Completed
Location
Colorado Blood Cancer Institute
Start Date
2015-12
Trial ID
NCT02441686
Treatments Being Tested
Aim: This randomised controlled experimental study was conducted to determi...
Status
Completed
Location
Tarsus University
Start Date
2023-05-01
Trial ID
NCT06312228
Treatments Being Tested
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
The objective of this trial was to explore the dose-response relation of su...
Status
Completed
Location
Multiple Locations
Start Date
2004-03-04
Trial ID
NCT00535743
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
This is a clinical trial that will compare survival and sickle related outc...
Status
Completed
Location
Benioff Children's Hospital at Oakland
Start Date
2017-03-16
Trial ID
NCT02766465
The purpose of the study is to evaluate the immunogenicity and safety of Ki...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-31
Trial ID
NCT00871117
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-01
Trial ID
NCT02058563
Treatments Being Tested